.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,342,620

« Back to Dashboard

Details for Patent: 5,342,620

Title: Use of borate-polyol complexes in ophthalmic compositions
Abstract:Aqueous ophthalmic compositions containing water-soluble borate-polyol complexes are useful in aqueous ophthalmic compositions containing polyvinyl alcohol. These compositions provide the benefits of a borate buffering system, such as enhanced antimicrobial activity, without the problems associated with the use of borate and pol, such as formation of borate-polyvinyl alcohol complexes which are water-insoluble.
Inventor(s): Chowhan; Masood (Arlington, TX)
Assignee: Alcon Laboratories, Inc. (Fort Worth, TX)
Filing Date:Sep 07, 1993
Application Number:08/118,833
Claims:1. A method of preparing an aqueous ophthalmic composition, comprising the steps of preparing a water-soluble borate-polyol complex by mixing borate and a polyol together in a aqueous solvent and adding polyvinyl alcohol thereto, wherein the water-soluble borate-polyol complex is present at a concentration between about 0.5 to about 6.0 wt %.

2. An aqueous ophthalmic composition prepared in accordance with the method of claim 1, comprising polyvinyl alcohol and a water-soluble borate-polyol complex, wherein the water-soluble borate-polyol complex is present at a concentration between about 0.5 to about 6.0 wt %.

3. The aqueous composition of claim 2, wherein the water-soluble borate-polyol complex comprises borate and polyol in a molar ratio between about 1:1 and about 1:10.

4. The aqueous composition of claim 2, wherein the water-soluble borate-polyol complex is present at a concentration between about 1.0 and about 2.5 wt %.

5. The aqueous composition of claim 2, wherein the water-soluble borate-polyol complex comprises a polyol selected from the group consisting of sugars, sugar alcohols and sugar acids.

6. The aqueous composition of claim 3, wherein the polyol is selected from the group consisting of mannitol, glycerin, propylene glycol and sorbitol.

7. The aqueous composition of claim 6, wherein the polyol is selected from the group consisting of mannitol and glycerin.

8. The aqueous composition of claim 7, wherein the polyol is mannitol.

9. The method of claim 1, wherein the water-soluble borate-polyol complex comprises borate and polyol in a molar ratio between about 1:1 and about 1:10.

10. The method of claim 1, wherein the concentration of the water-soluble borate-polyol complex in the final composition is between about 0.5 and about 0.3 wt %.

11. The method of claim 10, wherein the concentration of the water-soluble borate-polyol complex in the final composition is between about 1.0 and about 2.0 wt %.

12. The method of claim 1, wherein the water-soluble borate-polyol complex comprises a polyol selected from the group consisting of sugars, sugar alcohols and sugar acids.

13. The method of claim 12, wherein the polyol is selected from the group consisting of mannitol, glycerin, propylene glycol and sorbitol.

14. The method of claim 13, wherein the polyol is selected from the group consisting of mannitol and glycerin.

15. The method of claim 14, wherein the polyol is mannitol.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc